SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-322560
Filing Date
2018-11-08
Accepted
2018-11-08 16:14:04
Documents
55
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d646040d10q.htm 10-Q 593369
2 EX-31.1 d646040dex311.htm EX-31.1 6351
3 EX-31.2 d646040dex312.htm EX-31.2 6747
4 EX-32.1 d646040dex321.htm EX-32.1 6692
  Complete submission text file 0001193125-18-322560.txt   3166643

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cfrx-20180930.xml EX-101.INS 550084
6 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20180930.xsd EX-101.SCH 38171
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20180930_cal.xml EX-101.CAL 47823
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20180930_def.xml EX-101.DEF 107831
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20180930_lab.xml EX-101.LAB 306720
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20180930_pre.xml EX-101.PRE 212226
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 181169836
SIC: 2834 Pharmaceutical Preparations